Greek Prime Minister Kyriakos Mitsotakis recently visited the renovated Egaleo Health Center in Athens, highlighting Greece's continued investment in strengthening primary healthcare services and modernising the National Health System (NHS). During the visit, the Prime Minister toured the upgraded facility, met with healthcare professionals and earned about the centre's enhanced diagnostic services and clinical capabilities.
Greek Prime Minister Kyriakos Mitsotakis views the Wondfo Accre 8 Chemiluminescence Immunoassay Analyzer during his visit to the Egaleo Health Center in Athens.
The Egaleo Health Center is one of more than 110 primary healthcare facilities across Greece that have been renovated and upgraded through the country's Recovery Fund. Serving more than 65,000 residents in western Athens, the centre now provides comprehensive diagnostic, treatment and preventive healthcare services, supported by upgraded infrastructure, expanded clinical services and modern laboratory equipment.
Among the diagnostic technologies supporting the centre's laboratory services is the Wondfo Accre 8 Chemiluminescence Immunoassay Analyzer. Designed for primary care, emergency departments and decentralised laboratory settings, the compact analyser delivers rapid chemiluminescence immunoassay testing with a streamlined workflow. The system features single-dose reagent cartridges and is designed to deliver a first result in as little as 10 minutes, with throughput of up to 36 tests per hour, helping healthcare providers improve workflow efficiency while maintaining reliable immunoassay performance.
ACCRE 8
During the visit, Prime Minister Mitsotakis reaffirmed the Greek government's commitment to strengthening the National Health System through continued investment in healthcare infrastructure, diagnostic capabilities and preventive care.
The deployment of Wondfo Accre 8 at the Egaleo Health Center reflects Wondfo's commitment to supporting accessible, high-quality diagnostics in real-world clinical settings. By partnering with healthcare providers around the world, Wondfo continues to deliver innovative diagnostic solutions that contribute to stronger healthcare systems and better patient care.
The first developed technology platform with various application scenarios, including infectious disease, fertility, DOA, etc.
50+ kinds of reagents and five high-performance devices, focusing on detecting cardiovascular disease, inflammation, kidney injury, sex hormones, thyroid function, diabetes, tumor, and others.
Single-dose Chemiluminescense Immunoassay Platform
Wondfo optical blood coagulation analyzer is the first one in the world that can test PT, APTT, TT, FIB, and ACT simultaneously.
Our Blood Gas Analyzer BGA-102 can produce the result in 30s. Its advantages of portability, easy operation, durability, and high performance make it ideal for clinics, laboratories, and hospitals.
Ready-to-use lyophilized RT-PCR Reagent；
Wondfo PA-3600 IHC Staining System
The Wondfo Truth-H80E HPLC Hemoglobin Analyzer is a high-performance diagnostic device designed for rapid and precise measurement of glycosylated hemoglobin (HbA1c)—the gold standard for diabetes diagnosis.It support the standard mode and variant mode and provide the result within 60-90seconds.
Finecare™ Vitamin D, from complexity to simplicity
Building A World Free from Antibitoic Overuse
Advanced rapid diagnostic test with WHO prequalification for infectious disease
The Future Intelligent Medical Assistant to Healthcare
Fight against the pandemic through continuous innovation
Request
